Crystalline form of ticagrelor and manufacturing method and usage thereof

Disclosed is a new crystalline form of ticagrelor, manufacturing method thereof, and usage thereof in the manufacture of medicines used for reducing arterial thrombosis in patients with acute coronary syndrome.